HIV-1 reverse transcriptase discriminates against non-self tRNA primers

被引:43
|
作者
Essink, BBO [1 ]
Das, AT [1 ]
Berkhout, B [1 ]
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT HUMAN RETROVIROL,NL-1105 AZ AMSTERDAM,NETHERLANDS
关键词
reverse transcription; HIV-1; retrovirus; tRNA primer; primer-binding site;
D O I
10.1006/jmbi.1996.0638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interactions between the Reverse Transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) and the natural tRNA(Lys3) primer for initiation of viral DNA synthesis were examined. We constructed a set of HIV-1 RNA templates in which the wild-type primer binding site (PBSLys3) is replaced by sequences complementary to tRNA(lie), tRNA(Lys1,2), tRNA(Phe), tRNA(Pro) or tRNA(Trp) and tested the ability of RT enzymes of different retroviral species to initiate cDNA synthesis from self versus non-self tRNA primers. We demonstrate that initiation of HIV-1 reverse transcription is a specific process that is most efficient with the self tRNA(Lys3) primer. Interestingly, the property of HIV-1 RT to discriminate against non-self tRNA primers is lost upon extension of the tRNA by only two deoxyribonucleotides. Furthermore, selective tRNA priming by HIV-1 RT was not observed with viral RNA-tRNA(Lys3) duplexes isolated from HIV-1 virion particles, suggesting that the majority of tRNA(Lys3) primers annealed to viral RNA in particles is extended by a variable number of deoxyribonucleotides. This result indicates that reverse transcription is initiated relatively early in nascently assembled virions. (C) 1996 Academic Press Limited
引用
收藏
页码:243 / 254
页数:12
相关论文
共 50 条
  • [1] Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase
    Ilina, Tatiana V.
    Slack, Ryan L.
    Elder, John H.
    Sarafianos, Stefan G.
    Parniak, Michael A.
    Ishima, Rieko
    JOURNAL OF MOLECULAR BIOLOGY, 2018, 430 (13) : 1891 - 1900
  • [2] Murine leukemia virus reverse transcriptase:: Structural comparison with HIV-1 reverse transcriptase
    Cote, Marie L.
    Roth, Monica J.
    VIRUS RESEARCH, 2008, 134 (1-2) : 186 - 202
  • [3] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [4] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [5] Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3)(Lys) and DNA-tRNA(3)(Lys) hybrids
    Yusupova, G
    Lanchy, JM
    Yusupov, M
    Keith, G
    LeGrice, SFJ
    Ehresmann, C
    Ehresmann, B
    Marquet, R
    JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (03) : 315 - 321
  • [6] Novel HIV-1 reverse transcriptase inhibitors
    Jochmans, Dirk
    VIRUS RESEARCH, 2008, 134 (1-2) : 171 - 185
  • [7] Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase
    Andreola, M. L.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (21) : 2508 - 2519
  • [8] HIV-1 Reverse Transcriptase Dissociates during Strand Transfer
    Muchiri, John M.
    Rigby, Sean T.
    Nguyen, Laura A.
    Kim, Baek
    Bambara, Robert A.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 412 (03) : 354 - 364
  • [9] HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1
    Starodubova, Elizaveta
    Boberg, Andreas
    Kashuba, Elena V.
    Wahren, Britta
    Karpov, Vadim
    Isaguliants, Maria
    VACCINE, 2006, 24 (21) : 4541 - 4547
  • [10] Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Famiglini, Valeria
    Silvestri, Romano
    MOLECULES, 2016, 21 (02):